Avvinity is developing novel immunotherapeutics targeted to cancer, harnessing a natural immune adaptation by humans and other primates.
Location: United Kingdom, England, Landbeach
Member count: 11-50
Founded date: 2016
Investors 1
| Date | Name | Website |
| 24.09.2020 | NCL Techno... | ncltv.co.u... |
Mentions in press and media 2
| Date | Title | Description | Category | Author | Source |
| 23.09.2020 | LifeArc an... | LifeArc and UK government’s Fu... | - | - | lifearc.or... |
| 02.03.2016 | Horizon Di... | Horizon Discovery Group forms ... | - | - | cambridgen... |